Market Forecast By Type (Deep Transcranial Magnetic Stimulator (dTMS), Repetitive Transcranial Magnetic Stimulator (rTMS)), By Application (AlzheimersDisease, Depression, ParkinsonsDisease, Epilepsy), By End Use (Research, Diagnostics, Therapeutics) And Competitive Landscape
| Product Code: ETC6741176 | Publication Date: Sep 2024 | Updated Date: Mar 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, China saw a steady increase in deep transcranial magnetic stimulation (DTMS) device imports, with top exporting countries being Mexico, USA, Costa Rica, Ireland, and Japan. Despite the slight decline in growth rate from 2023 to 2024, the Herfindahl-Hirschman Index (HHI) remained at low concentration levels, indicating a competitive market landscape. The compound annual growth rate (CAGR) from 2020 to 2024 was 0.45%, reflecting a stable upward trend in import volumes. This data suggests a continued interest and demand for DTMS devices in the Chinese market.

According to 6Wresearch internal database and industry insights, the China Deep Transcranial Magnetic Stimulation Device Market is projected to grow at a compound annual growth rate (CAGR) of 9.4% during the forecast period (2026-2032).
The China Deep Transcranial Magnetic Stimulation Device Market report thoroughly covers the market by type, application, and end use. The market report provides an unbiased and detailed analysis of ongoing market trends, opportunities/high growth areas, and market drivers, which help stakeholders devise and align their market strategies according to the current and future market dynamics.
| Report Name | China Deep Transcranial Magnetic Stimulation Device Market |
| Forecast period | 2026-2032 |
| CAGR | 9.4% |
| Growing Sector | Therapeutics |
China Deep Transcranial Magnetic Stimulation Device Market is anticipated to record strong growth owing to the increasing prevalence of neurological and psychiatric disorders, rising awareness of non-invasive treatment methods, and rapid expansion of advanced healthcare technologies. The demand for dTMS devices is increasing with growing interest in improving mental health conditions with innovative therapies. Furthermore, healthcare reforms with government support and investments in neurotechnology research are helping to promote dTMS device usage in hospitals and clinics in China.
Below mentioned are some prominent drivers and their influence on the market dynamics:
| Drivers | Primary Segments Affected | Why it Matters (Evidence) |
| Rising Mental Health Awareness | dTMS; Therapeutics | Increasing diagnosis of depression and anxiety boosts demand for advanced therapies. |
| Expansion of Neurology Clinics | rTMS; Diagnostics & Therapeutics | More specialized centers provide more access to neuromodulation therapy. |
| Technological Advancements in Devices | dTMS; Research | Better device efficiency increases the rate of successful clinical trials. |
| Government Healthcare Reforms | All Types; Hospitals | Government support of mental healthcare fuels infrastructure development. |
| Growing Aging Population | dTMS & rTMS; Therapeutics | Higher incidence of neurological disorders increases treatment demand. |
China Deep Transcranial Magnetic Stimulation Device Market is expected to grow at the CAGR of 9.4% during the forecast period of 2026-2032. The market is growing due to the rising burden of neurological disorders, which includes depression, Parkinson’s disease, and Alzheimer’s disease. Furthermore, there is a growing trend towards using non-invasive treatment solutions. The rising healthcare infrastructure and increased investments in neurotechnology research are also contributing to the adoption of neurology devices. The presence of local players and their association with global players also add value to the accessibility of neurology devices. Government initiatives towards mental health also contribute to the rising diagnosis rate, thus driving the market.
Below mentioned are some major restraints and their influence on the market dynamics:
| Restraints | Primary Segments Affected | What This Means (Evidence) |
| High Device Costs | dTMS; Therapeutics | Expensive equipment limits adoption in smaller healthcare facilities. |
| Limited Skilled Professionals | All Types; Hospitals | Lack of trained specialists restricts proper device utilization. |
| Regulatory Approval Delays | rTMS; Research | Lengthy approval processes slow product commercialization. |
| Low Awareness in Rural Areas | All Types; Diagnostics | Limited knowledge reduces early adoption of advanced treatments. |
| Maintenance and Operational Costs | dTMS; Clinics | High upkeep costs impact long-term affordability for clinics. |
Irrespective of massive growth and development, the China Deep Transcranial Magnetic Stimulation Device Industry is facing some issues like high investment costs, uneven distribution of advanced healthcare facilities in rural and urban areas, and the lack of trained professionals in hospitals to effectively operate these sophisticated machines. In addition, there are issues related to the regulation and approval processes, which may affect the timely availability of new products in the market. Further, there is a concern related to the cost factor, which may affect small clinics and patients, and awareness related to non-invasive brain treatments, which may affect the growth of the China Deep Transcranial Magnetic Stimulation Device Industry in different regions.
Key trends shaping the China Deep Transcranial Magnetic Stimulation Device Market Growth include:
Key areas attracting investment in the China Deep Transcranial Magnetic Stimulation Device Market include:
Some leading players operating in the China Deep Transcranial Magnetic Stimulation Device Market include:
| Company Name | BrainsWay Ltd. |
| Established Year | 2003 |
| Headquarters | Jerusalem, Israel |
| Official Website | Click Here |
BrainsWay specializes in deep transcranial magnetic stimulation systems designed for treating depression and neurological disorders. The company focuses on innovative coil designs and clinical research to enhance treatment effectiveness and expand its presence in global healthcare markets including China.
| Company Name | MagVenture A/S |
| Established Year | 1992 |
| Headquarters | Farum, Denmark |
| Official Website | Click Here |
MagVenture develops advanced transcranial magnetic stimulation devices used in both research and clinical applications. Its products are widely adopted in psychiatric and neurological treatments, offering precision therapy solutions.
| Company Name | Neurosoft Ltd. |
| Established Year | 1992 |
| Headquarters | Ivanovo, Russia |
| Official Website | Click Here |
Neurosoft provides a range of neurodiagnostic and neurostimulation equipment, including TMS systems. The company focuses on affordability and accessibility, making its devices suitable for expanding healthcare infrastructure in emerging markets like China.
| Company Name | Nexstim Plc |
| Established Year | 2000 |
| Headquarters | Helsinki, Finland |
| Official Website | Click Here |
Nexstim offers navigated brain stimulation systems that enhance treatment accuracy for neurological conditions. Its advanced technology supports personalized therapy approaches, making it a key player in the growing Chinese neurostimulation market.
| Company Name | Yiruide Medical Equipment Co., Ltd. |
| Established Year | 2000 |
| Headquarters | Wuhan, China |
| Official Website | Click Here |
Yiruide is a domestic manufacturer specializing in rehabilitation and neurostimulation devices. The company plays a crucial role in supplying cost-effective TMS solutions within China, supporting broader adoption across hospitals and research institutions.
According to China’s Government Data, multiple initiatives have been introduced to strengthen neurological healthcare and promote the adoption of advanced medical devices. For instance, the Healthy China 2030 plan focuses on mental health awareness and the adoption of innovative medical technologies in the treatment of mental disorders. Secondly, there has been a facilitation of approval processes for advanced medical equipment, thus allowing a quicker market rollout of TMS technology. There is also financial support being offered to public hospitals, which has helped in the upgrade of facilities, thus increasing accessibility in both urban and semi-urban regions.
The China Deep Transcranial Magnetic Stimulation Device Market is expected to witness sustained growth This is due to increased investments in healthcare infrastructure and constant improvements in neurotechnology. The increase in the occurrence of neurological disorders, as well as the acceptance of non-invasive treatments, will also contribute to the increased adoption of devices in hospitals and clinics. Additionally, the continued support from governments in mental health programs and funding will further increase innovations in the field.
The report offers a comprehensive study of the subsequent market segments and their leading categories.
According to Rahul, Senior Research Analyst, 6Wresearch, the Deep Transcranial Magnetic Stimulator (dTMS) category captures the highest market share in the China Deep Transcranial Magnetic Stimulation Device Market, primarily due to its effectiveness in treating depression and neurological disorders. The dominance of this segment can be attributed to the superior efficacy of this device in penetrating deeper into the brain, making it highly effective for treating various neurological and psychiatric disorders such as depression and Parkinson’s disease. Furthermore, increasing validation of this treatment method, growing physician affinity towards delivering superior treatment results, and increasing investment in innovative neurostimulation techniques are expected to boost the dominance of dTMS-based medical devices.
Depression appears to be the leading application segment of the global dTMS device market. This dominance can be attributed to the growing prevalence of mental health disorders, coupled with increasing awareness of superior treatment methods. Healthcare organizations are increasingly opting for dTMS-based medical devices as an alternative treatment method for various neurological disorders, especially treatment-resistant depressions.
The report offers a comprehensive study of the subsequent market segments:
|
1 Executive Summary |
|
2 Introduction |
|
2.1 Key Highlights of the Report |
|
2.2 Report Description |
|
2.3 Market Scope & Segmentation |
|
2.4 Research Methodology |
|
2.5 Assumptions |
|
3 China Deep Transcranial Magnetic Stimulation (DTMS) Device Market Overview |
|
3.1 China Country Macro Economic Indicators |
|
3.2 China Deep Transcranial Magnetic Stimulation (DTMS) Device Market Revenues & Volume, 2022 & 2032F |
|
3.3 China Deep Transcranial Magnetic Stimulation (DTMS) Device Market - Industry Life Cycle |
|
3.4 China Deep Transcranial Magnetic Stimulation (DTMS) Device Market - Porter's Five Forces |
|
3.5 China Deep Transcranial Magnetic Stimulation (DTMS) Device Market Revenues & Volume Share, By Type, 2022 & 2032F |
|
3.6 China Deep Transcranial Magnetic Stimulation (DTMS) Device Market Revenues & Volume Share, By Application, 2022 & 2032F |
|
3.7 China Deep Transcranial Magnetic Stimulation (DTMS) Device Market Revenues & Volume Share, By End Use, 2022 & 2032F |
|
4 China Deep Transcranial Magnetic Stimulation (DTMS) Device Market Dynamics |
|
4.1 Impact Analysis |
|
4.2 Market Drivers |
|
4.2.1 Increasing prevalence of neurological disorders in China |
|
4.2.2 Growing awareness and acceptance of non-invasive treatment options |
|
4.2.3 Technological advancements in deep transcranial magnetic stimulation (DTMS) devices |
|
4.3 Market Restraints |
|
4.3.1 Stringent regulatory requirements for medical devices in China |
|
4.3.2 Limited reimbursement policies for DTMS therapy |
|
4.3.3 High initial cost of DTMS devices and treatments |
|
5 China Deep Transcranial Magnetic Stimulation (DTMS) Device Market Trends |
|
6 China Deep Transcranial Magnetic Stimulation (DTMS) Device Market, By Types |
|
6.1 China Deep Transcranial Magnetic Stimulation (DTMS) Device Market, By Type |
|
6.1.1 Overview and Analysis |
|
6.1.2 China Deep Transcranial Magnetic Stimulation (DTMS) Device Market Revenues & Volume, By Type, 2022- 2032F |
|
6.1.3 China Deep Transcranial Magnetic Stimulation (DTMS) Device Market Revenues & Volume, By Deep Transcranial Magnetic Stimulator (dTMS), 2022- 2032F |
|
6.1.4 China Deep Transcranial Magnetic Stimulation (DTMS) Device Market Revenues & Volume, By Repetitive Transcranial Magnetic Stimulator (rTMS), 2022- 2032F |
|
6.2 China Deep Transcranial Magnetic Stimulation (DTMS) Device Market, By Application |
|
6.2.1 Overview and Analysis |
|
6.2.2 China Deep Transcranial Magnetic Stimulation (DTMS) Device Market Revenues & Volume, By AlzheimersDisease, 2022- 2032F |
|
6.2.3 China Deep Transcranial Magnetic Stimulation (DTMS) Device Market Revenues & Volume, By Depression, 2022- 2032F |
|
6.2.4 China Deep Transcranial Magnetic Stimulation (DTMS) Device Market Revenues & Volume, By ParkinsonsDisease, 2022- 2032F |
|
6.2.5 China Deep Transcranial Magnetic Stimulation (DTMS) Device Market Revenues & Volume, By Epilepsy, 2022- 2032F |
|
6.3 China Deep Transcranial Magnetic Stimulation (DTMS) Device Market, By End Use |
|
6.3.1 Overview and Analysis |
|
6.3.2 China Deep Transcranial Magnetic Stimulation (DTMS) Device Market Revenues & Volume, By Research, 2022- 2032F |
|
6.3.3 China Deep Transcranial Magnetic Stimulation (DTMS) Device Market Revenues & Volume, By Diagnostics, 2022- 2032F |
|
6.3.4 China Deep Transcranial Magnetic Stimulation (DTMS) Device Market Revenues & Volume, By Therapeutics, 2022- 2032F |
|
7 China Deep Transcranial Magnetic Stimulation (DTMS) Device Market Import-Export Trade Statistics |
|
7.1 China Deep Transcranial Magnetic Stimulation (DTMS) Device Market Export to Major Countries |
|
7.2 China Deep Transcranial Magnetic Stimulation (DTMS) Device Market Imports from Major Countries |
|
8 China Deep Transcranial Magnetic Stimulation (DTMS) Device Market Key Performance Indicators |
|
8.1 Adoption rate of DTMS therapy in China |
|
8.2 Number of clinical trials and research studies on DTMS in China |
|
8.3 Rate of development and commercialization of new DTMS devices in China |
|
9 China Deep Transcranial Magnetic Stimulation (DTMS) Device Market - Opportunity Assessment |
|
9.1 China Deep Transcranial Magnetic Stimulation (DTMS) Device Market Opportunity Assessment, By Type, 2022 & 2032F |
|
9.2 China Deep Transcranial Magnetic Stimulation (DTMS) Device Market Opportunity Assessment, By Application, 2022 & 2032F |
|
9.3 China Deep Transcranial Magnetic Stimulation (DTMS) Device Market Opportunity Assessment, By End Use, 2022 & 2032F |
|
10 China Deep Transcranial Magnetic Stimulation (DTMS) Device Market - Competitive Landscape |
|
10.1 China Deep Transcranial Magnetic Stimulation (DTMS) Device Market Revenue Share, By Companies, 2025 |
|
10.2 China Deep Transcranial Magnetic Stimulation (DTMS) Device Market Competitive Benchmarking, By Operating and Technical Parameters |
|
11 Company Profiles |
|
12 Recommendations |
|
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here